KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) EPS (Weighted Average and Diluted) (2016 - 2025)

HCA Healthcare (HCA) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $8.09 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 43.69% to $8.09 in Q4 2025 year-over-year; TTM through Dec 2025 was $28.33, a 28.77% increase, with the full-year FY2025 number at $28.33, up 28.77% from a year prior.
  • EPS (Weighted Average and Diluted) was $8.09 for Q4 2025 at HCA Healthcare, up from $6.96 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $8.09 in Q4 2025 to a low of $3.9 in Q2 2022.
  • A 5-year average of $5.48 and a median of $5.58 in 2024 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 258.97% in 2021, then plummeted 44.14% in 2022.
  • HCA Healthcare's EPS (Weighted Average and Diluted) stood at $5.73 in 2021, then grew by 25.31% to $7.18 in 2022, then decreased by 17.83% to $5.9 in 2023, then decreased by 4.58% to $5.63 in 2024, then soared by 43.69% to $8.09 in 2025.
  • Per Business Quant, the three most recent readings for HCA's EPS (Weighted Average and Diluted) are $8.09 (Q4 2025), $6.96 (Q3 2025), and $6.83 (Q2 2025).